Table 3.
Time intervals (days) between consecutive assessments.
| Questionnaires | M0-M6 | M6-M12 | M12-M18 | M18-M24 | M0-M24 | |||||||
| Multiple Sclerosis Quality of Life-54 | ||||||||||||
| Mean (SDb) | 177.82 (28.13) | 188.42 (37.20) | 180.25 (33.47) | 180.75 (27.89) | 724.05 (63.39) | |||||||
| Minimum | −42ª | 99 | −41ª | 0 | 1 | |||||||
| Maximum | 266 | 545 | 369 | 257 | 825 | |||||||
| Median (IQRc) | 182 (180-184) | 183 (182-185) | 182 (181-184) | 183 (181-186) | 730 (729-733) | |||||||
| Multiple Sclerosis Impact Profile | ||||||||||||
| Mean (SD) | 186.39 (35.86) | 188.93 (34.69) | 179.73 (31.44) | 180.15 (28.27) | 733.23 (21.13) | |||||||
| Minimum | 114 | 166 | −32ª | 0 | 547 | |||||||
| Maximum | 738 | 552 | 374 | 305 | 852 | |||||||
| Median (IQR) | 183 (182-186) | 183 (182.25-187) | 182 (179-183.25) | 183 (181-185) | 731 (730-734) | |||||||
| Medication and Adherence | ||||||||||||
| Mean (SD) | 188.10 (11.87) | 192.26 (49.86) | 220.67 (69.19) | 186.46 (47.43) | 763.75 (66.42) | |||||||
| Minimum | 182 | 89 | 150 | 103 | 675 | |||||||
| Maximum | 285 | 550 | 700 | 370 | 1093 | |||||||
| Median (IQR) | 185 (182-188) | 183 (180-188) | 197 (189-216) | 188 (152-200.5) | 749 (718-776) | |||||||
aNegative value because some respondents (MSQoL-54, N=3; MSIP, N=1) did not complete the consecutive questionnaires chronologically.
bSD: standard deviation.
cIQR: interquartile range.